SitesBLAST
Comparing Echvi_2513 FitnessBrowser__Cola:Echvi_2513 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
4etlA Crystallographic structure of phenylalanine hydroxylase from chromobacterium violaceum f258a mutation (see paper)
44% identity, 85% coverage: 18:242/264 of query aligns to 23:247/277 of 4etlA
3tcyA Crystallographic structure of phenylalanine hydroxylase from chromobacterium violaceum (cpah) bound to phenylalanine in a site distal to the active site (see paper)
44% identity, 86% coverage: 17:242/264 of query aligns to 22:247/277 of 3tcyA
Sites not aligning to the query:
1ltvA Crystal structure of chromobacterium violaceum phenylalanine hydroxylase, structure with bound oxidized fe(iii) (see paper)
44% identity, 86% coverage: 17:242/264 of query aligns to 20:245/275 of 1ltvA
1ltzA Crystal structure of chromobacterium violaceum phenylalanine hydroxylase, structure has bound iron (iii) and oxidized cofactor 7, 8-dihydrobiopterin (see paper)
44% identity, 86% coverage: 17:242/264 of query aligns to 22:247/274 of 1ltzA
2v27B Structure of the cold active phenylalanine hydroxylase from colwellia psychrerythraea 34h (see paper)
40% identity, 81% coverage: 26:239/264 of query aligns to 19:230/272 of 2v27B
P04177 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Rattus norvegicus (Rat) (see 7 papers)
34% identity, 85% coverage: 25:248/264 of query aligns to 225:454/498 of P04177
- Q310 (≠ P106) mutation to H: Does not affect Vmax for phenylalanine. Increases KM for phenylalanine.
- H323 (≠ Y119) mutation to Y: Does not affect Vmax for phenylalaninet. Increases KM for phenylalanine.
- H331 (= H127) binding
- H336 (= H132) binding
- W372 (= W170) mutation to F: Does not affect substrate specificity.
- E376 (= E174) binding
- D425 (≠ K223) Important for substrate specificity; mutation to V: Shifts substrate specificity from tyrosine to phenylalanine.
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 19 modified: Phosphoserine; by CaMK2
- 31 modified: Phosphoserine
- 40 modified: Phosphoserine; by CaMK2 and PKA
P90986 Tyrosine 3-monooxygenase; Abnormal catecholamine distribution protein 2; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Caenorhabditis elegans (see 4 papers)
35% identity, 81% coverage: 22:235/264 of query aligns to 238:453/519 of P90986
Sites not aligning to the query:
- 35 modified: Phosphoserine; by PKA
- 276:519 mutation Missing: In e1112; spontaneously induces activation of the crh-1/CREB1 transcription factor in cholinergic SIA neurons in the absence and presence of food. Reduces swimming-induced paralysis in response to amphetamine. Defective male mating behavior.
2tohA Tyrosine hydroxylase catalytic and tetramerization domains from rat (see paper)
34% identity, 85% coverage: 25:248/264 of query aligns to 63:292/336 of 2tohA
- active site: H169 (= H127), H174 (= H132), E214 (= E174), S233 (= S193)
- binding fe (iii) ion: H169 (= H127), H174 (= H132), E214 (= E174)
- binding 7,8-dihydrobiopterin: V129 (= V87), L132 (= L90), L133 (≠ I91), Y138 (≠ F96), P165 (= P123), E170 (≠ D128), Y209 (= Y169)
P17289 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Bos taurus (Bovine) (see 2 papers)
34% identity, 80% coverage: 25:236/264 of query aligns to 218:431/491 of P17289
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 19 modified: Phosphoserine; by CaMK2
- 31 modified: Phosphoserine
- 40 modified: Phosphoserine; by CaMK2 and PKA
P07101 Tyrosine 3-monooxygenase; Tyrosine 3-hydroxylase; TH; EC 1.14.16.2 from Homo sapiens (Human) (see 32 papers)
33% identity, 80% coverage: 25:236/264 of query aligns to 255:468/528 of P07101
- E259 (≠ N29) to G: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T276 (≠ N46) to P: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs28934581
- P301 (≠ A67) to A: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- F309 (≠ I75) to S: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T314 (= T80) to M: in ARSEGS; parkinsonian symptoms in infancy; loss of about 80% of tyrosine 3-monooxygenase activity; dbSNP:rs121917764
- R319 (≠ Q85) to P: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- R328 (≠ D94) to W: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs1428589694
- R337 (≠ K103) to H: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs28934580
- C359 (≠ M125) to F: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs121917765
- F375 (≠ Y141) to L: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs763198914
- A376 (≠ V142) to V: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
- L387 (= L153) to M: in ARSEGS; no effect on tyrosine 3-monooxygenase activity
- I394 (= I162) to T: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- T399 (≠ R167) to M: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs1057520384
- Q412 (≠ E180) to K: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; reduced affinity for L-tyrosine; dbSNP:rs121917762
- G414 (= G182) to R: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs370962049
- G428 (= G196) to R: in ARSEGS; phenotype with prominent levodopa-responsive myoconus-dystonia (M-D); dbSNP:rs1264884607
- R441 (= R209) to P: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs367874223
- S467 (= S235) to G: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity
Sites not aligning to the query:
- 19 modified: Phosphoserine; by CaMK2; S → C: found in a patient with ARSEGS; uncertain significance; dbSNP:rs766704202
- 62 modified: Phosphoserine; S→A: Affects subcellular localization. Accumulates mainly in the soma of the neuroblastoma cells.; S→E: Does not affect subcellular localization. Distributed throughout the soma and neurites.
- 71 modified: Phosphoserine; by CaMK2 and PKA; S→E: Suppresses feedback inhibition induced by dopamine. Suppresses feedback inhibition induced by dopamine; when associated with A-207.
- 112 V → M: in dbSNP:rs6356
- 207 C → Y: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; C→A: Suppresses the decrease in tyrosine 3-monooxygenase activity induced by NEM modification. Suppresses feedback inhibition induced by dopamine; when associated with E-71.
- 227 D → G: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
- 233 R → H: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs80338892
- 236 L → P: in ARSEGS; severe parkinsonian symptoms in early infancy; strongly reduced stability and tyrosine 3-monooxygenase activity; rare mutation; dbSNP:rs121917763
- 241 A → T: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs1260455415
- 246 H → Y: in ARSEGS; loss of about 40% of tyrosine 3-monooxygenase activity
- 247 G → S: in ARSEGS; loss of about 50% of tyrosine 3-monooxygenase activity; shifted substrate specificity from tyrosine to phenylalanine and Dopa; dbSNP:rs762304556
- 492 P → L: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity; dbSNP:rs767635052
- 494 T → M: in ARSEGS; parkinsonian symptoms in infancy; no effect on tyrosine 3-monooxygenase activity; dbSNP:rs45471299
- 498 D → G: in ARSEGS; loss of over 80% of tyrosine 3-monooxygenase activity; dbSNP:rs771351747
- 499 V → M: in dbSNP:rs1800033
- 510 L → Q: in ARSEGS; complete loss of tyrosine 3-monooxygenase activity
6zvpD Atomic model of the em-based structure of the full-length tyrosine hydroxylase in complex with dopamine (residues 40-497) in which the regulatory domain (residues 40-165) has been included only with the backbone atoms (see paper)
33% identity, 80% coverage: 25:236/264 of query aligns to 185:398/458 of 6zvpD
Sites not aligning to the query:
2xsnA Crystal structure of human tyrosine hydroxylase catalytic domain
33% identity, 80% coverage: 25:236/264 of query aligns to 63:276/335 of 2xsnA
6zn2A Partial structure of tyrosine hydroxylase in complex with dopamine showing the catalytic domain and an alpha-helix from the regulatory domain involved in dopamine binding. (see paper)
33% identity, 80% coverage: 25:236/264 of query aligns to 62:275/335 of 6zn2A
5jk8A Phenylalanine hydroxylase from dictyostelium - bh2, norleucine complex
33% identity, 81% coverage: 25:238/264 of query aligns to 144:359/390 of 5jk8A
- active site: H250 (= H127), H255 (= H132), E295 (= E174), S314 (= S193)
- binding fe (iii) ion: H250 (= H127), H255 (= H132), E295 (= E174)
- binding 7,8-dihydrobiopterin: L214 (≠ I91), A216 (≠ D93), F219 (= F96), S287 (= S166), Y290 (= Y169)
- binding norleucine: Y242 (= Y119), T243 (≠ L120), H250 (= H127), S314 (= S193), S315 (= S194)
- binding piperazine-n,n'-bis(2-ethanesulfonic acid): T203 (= T80), R226 (≠ K103), D266 (= D143)
Sites not aligning to the query:
5jk5A Phenylalanine hydroxylase from dictyostelium - bh2 complex
33% identity, 81% coverage: 25:238/264 of query aligns to 153:368/400 of 5jk5A
- active site: H259 (= H127), H264 (= H132), E304 (= E174), S323 (= S193)
- binding fe (iii) ion: H259 (= H127), H264 (= H132), E304 (= E174)
- binding 7,8-dihydrobiopterin: G221 (= G89), L222 (= L90), L223 (≠ I91), F228 (= F96), L229 (≠ F97), S296 (= S166), Y299 (= Y169)
- binding piperazine-n,n'-bis(2-ethanesulfonic acid): T212 (= T80), P271 (≠ Q139), D275 (= D143)
Sites not aligning to the query:
3e2tA The catalytic domain of chicken tryptophan hydroxylase 1 with bound tryptophan (see paper)
29% identity, 89% coverage: 25:260/264 of query aligns to 63:300/307 of 3e2tA
- active site: H169 (= H127), H174 (= H132), E214 (= E174), S233 (= S193)
- binding fe (iii) ion: H169 (= H127), H174 (= H132), E214 (= E174)
- binding imidazole: H169 (= H127), H174 (= H132), E214 (= E174)
- binding tryptophan: R154 (= R112), Y161 (= Y119), T162 (≠ L120), E164 (= E122), P165 (= P123), H169 (= H127), F215 (= F175), S233 (= S193), I263 (≠ K223)
P70080 Tryptophan 5-hydroxylase 1; Tryptophan 5-monooxygenase 1; EC 1.14.16.4 from Gallus gallus (Chicken) (see paper)
29% identity, 89% coverage: 25:260/264 of query aligns to 167:404/445 of P70080
- Y236 (≠ L90) binding
- R258 (= R112) binding
- T266 (≠ L120) binding
- H273 (= H127) binding
- H278 (= H132) binding
- E318 (= E174) binding
- S337 (= S193) binding
- I367 (≠ K223) binding
P16331 Phenylalanine-4-hydroxylase; PAH; Phe-4-monooxygenase; EC 1.14.16.1 from Mus musculus (Mouse) (see paper)
33% identity, 80% coverage: 25:236/264 of query aligns to 179:392/453 of P16331
- F263 (= F105) mutation to S: Mutant mice have features of phenylketonuria.
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylalanine
- 106 V→A: Mutant mice have mild features of phenylketonuria.
5fgjA Structure of tetrameric rat phenylalanine hydroxylase, residues 1-453 (see paper)
33% identity, 80% coverage: 25:236/264 of query aligns to 157:370/428 of 5fgjA
P04176 Phenylalanine-4-hydroxylase; PAH; Phe-4-monooxygenase; EC 1.14.16.1 from Rattus norvegicus (Rat) (see 2 papers)
33% identity, 80% coverage: 25:236/264 of query aligns to 179:392/453 of P04176
- H285 (= H127) binding
- H290 (= H132) binding
- E330 (= E174) binding
Sites not aligning to the query:
- 16 modified: Phosphoserine; by PKA
Query Sequence
>Echvi_2513 FitnessBrowser__Cola:Echvi_2513
MAGKSAEWVFEDPRLKAMHQDYDAYTEENFAVWKTLYERQIVNLPNAASKAYLEGIKEIN
FTADRIANFSEVNQILSKSTGWGVQVVPGLIDDDLFFGLLNHKRFPSSTWLRKMEQLDYL
EEPDMFHDAFAHMPMLTNQPYVDFLQDLSGIALKYIDDKWAIHLLSRIYWFTIEFGLIRE
NGALKIYGAGILSSAGETKFSLSDDPEHRDYDVRSIMQTPYWKDKFQDKYYVIESYEQLY
NSIPEIERVLAEELIANEDPEKEP
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory